Compounds > ergotamine

ergotamine and Obesity

ergotamine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjørn-Yoshimoto, WE; Che, T; Cheng, J; Ding, K; Gloriam, DE; Han, GW; Hanson, MA; Harpsøe, K; Huang, XP; Jensen, AA; Katritch, V; Lansu, K; Liu, ZJ; McCorvy, JD; Nikolajsen, LF; Peng, Y; Popov, P; Pu, M; Qu, L; Roth, BL; Shen, L; Stevens, RC; Wacker, D; Wu, Y; Yuan, S; Zhao, S1
Mathew, NT; Ravishankar, K; Sanin, LC1

Other Studies

2 other study(ies) available for ergotamine and Obesity

ArticleYear
5-HT
    Cell, 2018, 02-08, Volume: 172, Issue:4

    Topics: Ergotamine; HEK293 Cells; Humans; Obesity; Protein Domains; Receptor, Serotonin, 5-HT2C; Ritanserin; Schizophrenia; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship; Substance-Related Disorders

2018
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
    Neurology, 1996, Volume: 46, Issue:5

    Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan

1996